Concepedia
Statistics
Publications
42
Citations
2.1K
H-Index
24
Active since
1988
Affiliations
George Washington University(Current)
Washington University Medical Center
GlaxoSmithKline (United States)
The University of Texas Southwestern Medical Center
GlaxoSmithKline (Spain)
Michael J. Manyak is an author at George Washington University specializing in medicine, urology, and prostate disease.
Publications per year
1988–2020
Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
F A Attiga, Patricia M. Fernández, Ashani T. Weeraratna et al. · PubMed · 2000 · 307 citations
Medicine, Cancer Biology, Pharmacology +14
( <sup>111</sup> ) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
Daniel Kahn, Richard D. Williams, Michael J. Manyak et al. · The Journal of Urology · 1998 · 172 citations
Medicine, Surgery, Urology +13
Evaluation of Superficial Bladder Transitional-Cell Carcinoma by Optical Coherence Tomography
Michael J. Manyak, Natalia D. Gladkova, John H. Makari et al. · Journal of Endourology · 2005 · 116 citations
Medicine, Oncology, Urology +17
Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer
Michael J. Manyak, George H. Hinkle, John O. Olsen et al. · Urology · 1999 · 111 citations
Medicine, Nuclear Medicine, Oncology +14
Comparison of clinical staging algorithms and111Indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients
Thomas J. Polascik, Michael J. Manyak, Michael K. Haseman et al. · Cancer · 1999 · 105 citations
Medicine, Oncology, Surgery +17
1–5 of 42